Abstract
O-linked β-N-acetylglucosamine (O-GlcNAc) modification of proteins has been shown to be involved in many different cellular processes, such as cell cycle control, nutrient sensing, signal transduction, stress response and transcriptional regulation. Cells have developed complex regulatory systems in order to regulate gene expression appropriately in response to environmental and intracellular cues. Control of eukaryotic gene transcription often involves post-translational modification of a multitude of proteins including transcription factors, basal transcription machinery, and chromatin remodeling complexes to modulate their functions in a variety of manners. In this review we describe the emerging functional roles for and techniques to detect and modulate the O-GlcNAc modification and illustrate that the O-GlcNAc modification is intricately involved in at least seven different general mechanisms for the control of gene transcription.
Keywords: O-GlcNAc, transcriptional regulation, post-translational modification, review
Current Signal Transduction Therapy
Title: The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression
Volume: 5 Issue: 1
Author(s): Sandii Brimble, Edith E. Wollaston-Hayden, Chin Fen Teo, Andrew C. Morris and Lance Wells
Affiliation:
Keywords: O-GlcNAc, transcriptional regulation, post-translational modification, review
Abstract: O-linked β-N-acetylglucosamine (O-GlcNAc) modification of proteins has been shown to be involved in many different cellular processes, such as cell cycle control, nutrient sensing, signal transduction, stress response and transcriptional regulation. Cells have developed complex regulatory systems in order to regulate gene expression appropriately in response to environmental and intracellular cues. Control of eukaryotic gene transcription often involves post-translational modification of a multitude of proteins including transcription factors, basal transcription machinery, and chromatin remodeling complexes to modulate their functions in a variety of manners. In this review we describe the emerging functional roles for and techniques to detect and modulate the O-GlcNAc modification and illustrate that the O-GlcNAc modification is intricately involved in at least seven different general mechanisms for the control of gene transcription.
Export Options
About this article
Cite this article as:
Brimble Sandii, Wollaston-Hayden E. Edith, Teo Fen Chin, Morris C. Andrew and Wells Lance, The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression, Current Signal Transduction Therapy 2010; 5 (1) . https://dx.doi.org/10.2174/157436210790226465
DOI https://dx.doi.org/10.2174/157436210790226465 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Co-formulation of P-glycoprotein Substrate and Inhibitor in Nanocarriers: An Emerging Strategy for Cancer Chemotherapy
Current Cancer Drug Targets Single-Photon Emission Computed Tomography Tracers for Predicting and Monitoring Cancer Therapy
Current Pharmaceutical Biotechnology Methods for Identifying Cardiovascular Agents: A Review
Recent Patents on Cardiovascular Drug Discovery Virtual Screening and Molecular Docking: Discovering Novel c-KIT Inhibitors
Current Medicinal Chemistry Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1<sup>®</sup> can Overcome Drug Resistance in Osteosarcoma
Current Cancer Drug Targets Synthesis of Derivatives of Artesunate α-Aminophosphonate and Their Antimicrobial Activities
Letters in Drug Design & Discovery The Small Heat Shock Protein HspB8: Role in Nervous System Physiology and Pathology
CNS & Neurological Disorders - Drug Targets Etiologic Aspects of Pagets Disease of Bone
Current Rheumatology Reviews Synthetic and Natural Immunomodulators Acting as Interferon Inducers
Current Pharmaceutical Design A Review on Clinical Management and Pharmacological Therapy on Hereditary Haemorrhagic Telangiectasia (HHT)
Current Vascular Pharmacology Anti-tumor Drug Targets Analysis: Current Insight and Future Prospect
Current Drug Targets Cervical Cancer During Pregnancy – An Approach to Diagnosis and Management
Current Women`s Health Reviews Nanoparticles Based on Plasma Proteins for Drug Delivery Applications
Current Pharmaceutical Design Herpetic (Non-Cytomegalovirus) Retinal Infections in Patients with the Acquired Immunodeficiency Syndrome
Current HIV Research Targeting Microtubules to Inhibit Angiogenesis and Disrupt Tumour Vasculature:Implications for Cancer Treatment
Current Cancer Drug Targets Emergence of Functionalized Nanomedicines in Cancer Chemotherapy: Recent Advancements, Current Challenges and Toxicity Considerations
Recent Patents on Nanomedicine CDK Inhibitors: From the Bench to Clinical Trials
Current Drug Targets microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis
Current Cancer Therapy Reviews Green Factories for Biopharmaceuticals
Current Medicinal Chemistry Tyrosine Kinase Inhibitors
Current Cancer Drug Targets